Aliases & Classifications for Angiomyolipoma

MalaCards integrated aliases for Angiomyolipoma:

Name: Angiomyolipoma 12 55 44 15 73
Angiomyolipoma of Kidney 73

Classifications:



External Ids:

Disease Ontology 12 DOID:3314
MeSH 44 D018207
NCIt 50 C3734
SNOMED-CT 68 19929002
UMLS 73 C0206633

Summaries for Angiomyolipoma

Disease Ontology : 12 A cell type benign neoplasm that from perivascular epithelioid cells.

MalaCards based summary : Angiomyolipoma, also known as angiomyolipoma of kidney, is related to kidney angiomyolipoma and hepatic angiomyolipoma. An important gene associated with Angiomyolipoma is TSC2 (TSC Complex Subunit 2), and among its related pathways/superpathways are ERK Signaling and Pathways in cancer. The drugs Afinitor and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include kidney, liver and breast, and related phenotypes are cellular and behavior/neurological

Wikipedia : 76 Angiomyolipomas are the most common benign tumour of the kidney. Although regarded as benign,... more...

Related Diseases for Angiomyolipoma

Diseases related to Angiomyolipoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 234)
# Related Disease Score Top Affiliating Genes
1 kidney angiomyolipoma 33.9 MTOR TSC1 TSC2
2 hepatic angiomyolipoma 32.9 KIT MTOR TSC2
3 tuberous sclerosis 1 32.3 CCL26 TSC1 TSC2
4 tuberous sclerosis 2 32.0 MTOR TSC1 TSC2
5 tuberous sclerosis 30.5 CCL26 MTOR TSC1 TSC2
6 horseshoe kidney 30.5 ACTC1 TSC2
7 subependymal giant cell astrocytoma 30.5 MTOR TSC1 TSC2
8 lymphangioleiomyomatosis 30.3 DES ESR1 MTOR PGR TSC1 TSC2
9 lung leiomyoma 30.0 ESR1 PGR
10 autosomal dominant polycystic kidney disease 29.8 MTOR TSC1 TSC2
11 renal cell carcinoma, papillary, 1 28.9 KIT MITF MTOR
12 renal cell carcinoma, nonpapillary 28.7 KIT MITF MTOR TSC1 TSC2
13 perivascular epithelioid cell tumor 28.5 ACTC1 DES KIT PGR TSC2
14 cystic nephroma 28.5 ACTC1 DES KIT PGR
15 leiomyoma 27.5 ACTC1 DES ESR1 KIT PGR
16 childhood kidney angiomyolipoma 12.0
17 epithelioid type angiomyolipoma 11.9
18 multiple endocrine neoplasia, type i 10.9
19 polycystic kidney disease, infantile severe, with tuberous sclerosis 10.9
20 fibroblastic rheumatism 10.8 ACTC1 DES
21 angiolipoma 10.8 ACTC1 DES
22 cutaneous leiomyosarcoma 10.8 ACTC1 DES
23 botryoid rhabdomyosarcoma 10.8 ACTC1 DES
24 spindle cell lipoma 10.8 ACTC1 DES
25 parachordoma 10.8 ACTC1 DES
26 ossifying fibromyxoid tumor 10.8 ACTC1 DES
27 epithelioid leiomyosarcoma 10.8 ACTC1 DES
28 syringocystadenoma papilliferum 10.8 ACTC1 DES
29 adult hepatocellular carcinoma 10.8 TSC1 TSC2
30 congenital fibrosarcoma 10.8 ACTC1 DES
31 pleomorphic liposarcoma 10.7 ACTC1 DES
32 ischemic fasciitis 10.7 ACTC1 DES
33 multilocular clear cell renal cell carcinoma 10.7 TSC1 TSC2
34 reticulum cell sarcoma 10.7 ACTC1 DES
35 hepatitis 10.7
36 dedifferentiated liposarcoma 10.7 ACTC1 DES
37 cutaneous fibrous histiocytoma 10.7 ACTC1 DES
38 lissencephaly with cerebellar hypoplasia 10.7 TSC1 TSC2
39 glomus tumor 10.7 ACTC1 DES
40 lymphangiomatosis 10.7 DES PGR
41 spindle cell sarcoma 10.7 ACTC1 DES
42 non-langerhans-cell histiocytosis 10.7 ACTC1 DES
43 pseudosarcomatous fibromatosis 10.6 ACTC1 DES
44 pyogenic granuloma 10.6 ACTC1 MTOR
45 calcifying aponeurotic fibroma 10.6 ACTC1 PGR
46 epulis 10.6 DES PGR
47 bizarre leiomyoma 10.6 ACTC1 PGR
48 myxoid leiomyosarcoma 10.6 ACTC1 PGR
49 angiomatosis 10.6 CCL26 TSC2
50 plasmablastic lymphoma 10.6 DES MTOR

Graphical network of the top 20 diseases related to Angiomyolipoma:



Diseases related to Angiomyolipoma

Symptoms & Phenotypes for Angiomyolipoma

MGI Mouse Phenotypes related to Angiomyolipoma:

46 (show all 17)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.25 ACTC1 KIT DES ESR1 MITF TSC1
2 behavior/neurological MP:0005386 10.22 KIT DES ESR1 MITF TSC1 MTOR
3 cardiovascular system MP:0005385 10.21 ACTC1 KIT DES ESR1 TSC1 MTOR
4 homeostasis/metabolism MP:0005376 10.19 ACTC1 KIT DES ESR1 MITF TSC1
5 embryo MP:0005380 10.14 KIT ESR1 MITF TSC1 MTOR PGR
6 endocrine/exocrine gland MP:0005379 10.13 KIT ESR1 MITF TSC1 MTOR PGR
7 mortality/aging MP:0010768 10.13 ACTC1 KIT DES ESR1 MITF TSC1
8 growth/size/body region MP:0005378 10.11 ESR1 ACTC1 KIT MITF MTOR TSC1
9 integument MP:0010771 10.02 KIT ESR1 MITF TSC1 TSC2 PGR
10 muscle MP:0005369 9.95 ACTC1 KIT DES ESR1 TSC1 MTOR
11 normal MP:0002873 9.86 ACTC1 KIT ESR1 MITF MTOR PGR
12 limbs/digits/tail MP:0005371 9.85 ESR1 KIT MITF PGR TYR
13 neoplasm MP:0002006 9.85 KIT ESR1 TSC1 TSC2 PGR TYR
14 no phenotypic analysis MP:0003012 9.8 KIT ESR1 MITF PGR MTOR TYR
15 renal/urinary system MP:0005367 9.63 KIT ESR1 MTOR TSC1 TYR TSC2
16 reproductive system MP:0005389 9.5 KIT ESR1 MITF PGR TSC1 TYR
17 skeleton MP:0005390 9.17 ESR1 KIT MITF PGR MTOR TSC1

Drugs & Therapeutics for Angiomyolipoma

FDA approved drugs:

# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Afinitor 18 49 EVEROLIMUS Novartis March 2009

Drugs for Angiomyolipoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 46)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
2
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
3
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
4
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
5 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
6 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
7 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Antiparasitic Agents Phase 4
11 Antiprotozoal Agents Phase 4
12 Antimalarials Phase 4
13
Letrozole Approved, Investigational Phase 2 112809-51-5 3902
14
Propranolol Approved, Investigational Phase 2 525-66-6 4946
15
Octreotide Approved, Investigational Phase 2 83150-76-9 383414 6400441
16
Somatostatin Approved, Investigational Phase 2 38916-34-6, 51110-01-1 53481605
17
Menthol Approved Phase 2 2216-51-5 16666
18
Celecoxib Approved, Investigational Phase 2 169590-42-5 2662
19
Saracatinib Investigational Phase 2 379231-04-6
20 Steroid Synthesis Inhibitors Phase 2
21 Hormone Antagonists Phase 2
22 Hormones Phase 2
23 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
24 Estrogen Antagonists Phase 2
25 Estrogens Phase 2
26 Aromatase Inhibitors Phase 2
27 Adrenergic Agents Phase 2
28 Adrenergic Antagonists Phase 2
29 Adrenergic beta-Antagonists Phase 2
30 Gastrointestinal Agents Phase 2
31 Neurotransmitter Agents Phase 2
32 Angiogenesis Inhibitors Phase 2
33 Anti-Arrhythmia Agents Phase 2
34 Vasodilator Agents Phase 2
35 Antihypertensive Agents Phase 2
36 Antineoplastic Agents, Hormonal Phase 2
37 Analgesics Phase 2
38 Cyclooxygenase 2 Inhibitors Phase 2
39 Cyclooxygenase Inhibitors Phase 2
40 Analgesics, Non-Narcotic Phase 2
41 Peripheral Nervous System Agents Phase 2
42 Liver Extracts Phase 2
43 Anti-Inflammatory Agents Phase 2
44 Anti-Inflammatory Agents, Non-Steroidal Phase 2
45 Antirheumatic Agents Phase 2
46 Cola Nutraceutical Phase 2

Interventional clinical trials:

(show all 22)
# Name Status NCT ID Phase Drugs
1 Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis Completed NCT01217125 Phase 4 Sirolimus
2 Doxycycline In Lymphangioleiomyomatosis (LAM) Completed NCT00989742 Phase 4 Doxycycline;Placebo
3 Phase IV Study of Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. Not yet recruiting NCT03525834 Phase 4 everolimus
4 Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00790400 Phase 3 Everolimus (RAD001);Everolimus Placebo
5 Sirolimus in Treating Patients With Angiomyolipoma of the Kidney Unknown status NCT00126672 Phase 2 sirolimus
6 Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM Unknown status NCT00490789 Phase 2 sirolimus
7 Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer Unknown status NCT02188550 Phase 2 everolimus and letrozole
8 Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers Completed NCT02104011 Phase 2 Propranolol
9 RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM Completed NCT00457964 Phase 1, Phase 2 RAD001
10 Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00792766 Phase 1, Phase 2 everolimus (RAD001)
11 Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM Completed NCT00457808 Phase 2 Rapamycin, sirolimus
12 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Completed NCT00005906 Phase 2 Octreotide
13 Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Recruiting NCT02539459 Phase 2 Everolimus
14 A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD Recruiting NCT02451696 Phase 2 Everolimus
15 COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC Recruiting NCT02484664 Phase 2 Celecoxib
16 Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis Recruiting NCT02737202 Phase 2 saracatinib
17 A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Withdrawn NCT01690871 Phase 2 BEZ235
18 Tuberous Sclerosis Complex Natural History Study: Renal Manifestations Completed NCT00598455
19 Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Recruiting NCT02325505
20 Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France Recruiting NCT02887781
21 EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications Recruiting NCT03477149 Not Applicable
22 A National Registry on Chinese Patients With Lymphangioleiomyomatosis Recruiting NCT03193892

Search NIH Clinical Center for Angiomyolipoma

Cochrane evidence based reviews: angiomyolipoma

Genetic Tests for Angiomyolipoma

Anatomical Context for Angiomyolipoma

MalaCards organs/tissues related to Angiomyolipoma:

41
Kidney, Liver, Breast, Lung, Endothelial, Colon, Brain

Publications for Angiomyolipoma

Articles related to Angiomyolipoma:

(show top 50) (show all 865)
# Title Authors Year
1
Huge retroperitoneal epithelioid angiomyolipoma: A case report. ( 29276686 )
2018
2
mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma. ( 29340326 )
2018
3
A rare case of giant renal angiomyolipoma in a woman with tuberous sclerosis. ( 29942788 )
2018
4
Angiomyolipoma of the Liver without a Fat Component, Mimicking a Hepatocellular Carcinoma. ( 29361814 )
2018
5
Massive hematuria at pregnancy caused by ruptured angiomyolipoma: A case report. ( 29254628 )
2018
6
Consequences of delay in screening, monitoring, and treatment of angiomyolipoma and tuberous sclerosis: A case reporta8c. ( 29701176 )
2018
7
Two in One: Epithelioid angiomyolipoma within a classic kidney angiomyolipoma - a case report. ( 29843640 )
2018
8
Sporadic renal angiomyolipoma in a patient with Birt-Hogg-DubAc: chaperones in pathogenesis. ( 29774133 )
2018
9
Hepatic angiomyolipoma detected using computed tomography. ( 29392859 )
2018
10
Hepatic epithelioid angiomyolipoma with renal metastasis: radiologic-pathologic correlation. ( 29955240 )
2018
11
Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness. ( 29697822 )
2018
12
Re: Diagnostic Performance of CT for Diagnosis of Fat-Poor Angiomyolipoma in Patients with Renal Masses: A Systematic Review and Meta-Analysis. ( 29783555 )
2018
13
A rare highly aggressive tumor of the kidney: The pure epithelioid angiomyolipoma. ( 29785369 )
2018
14
Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomised EXIST-1 and EXIST-2 studies. ( 29569806 )
2018
15
Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors. ( 29920561 )
2018
16
The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma. ( 28993887 )
2018
17
Retroperitoneal laparoscopic nephron sparing surgery for large renal angiomyolipoma: Our technique and experience. A case series of 41 patients. ( 29723675 )
2018
18
Bilateral Giant Renal Angiomyolipoma in a Patient with Tuberous Sclerosis Complex: A Case Report. ( 29686177 )
2018
19
Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation. ( 29764404 )
2018
20
Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis. ( 29512829 )
2018
21
Spontaneous reduction of native kidney size involving angiomyolipoma lesions in a kidney transplant recipient with tuberous sclerosis complex. ( 29417638 )
2018
22
Extrarenal retroperitoneal angiomyolipoma with oncocytoma. ( 29343920 )
2018
23
Gemstone spectral imaging dual-energy computed tomography for differentiation of renal cell carcinoma and minimal-fat renal angiomyolipoma. ( 29970695 )
2018
24
Pulmonary lymphangioleiomyomatosis associated with aggressive renal angiomyolipoma. ( 29686563 )
2018
25
Expression of MDM2 and p16 in Angiomyolipoma. ( 29432785 )
2018
26
Aggressive Renal Angiomyolipoma in a Patient with Tuberous Sclerosis Resulting in Pulmonary Tumor Embolus and Pulmonary Infarction<sup/>. ( 29885779 )
2018
27
Giant Extrarenal Retroperitoneal Angiomyolipoma: A Rare Case of a Large Size Tumor. ( 29980448 )
2018
28
Angiomyolipoma of the Kidneys: Current Perspectives and Challenges in Diagnostic Imaging and Image-Guided Therapy. ( 29685402 )
2018
29
Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid Angiomyolipoma: series of 4 primary tumors and 2 metastases. ( 29885406 )
2018
30
Hepatic angiomyolipoma presenting as an arterially enhancing liver lesion. ( 29392818 )
2018
31
Malignant renal epithelioid angiomyolipoma with TFE3 gene amplification mimicking renalA carcinoma. ( 29951351 )
2018
32
Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center. ( 29333579 )
2018
33
Superselective Transcatheter Arterial Embolization for Large Unruptured Renal Angiomyolipoma in Lymphangioleiomyomatosis. ( 29398412 )
2018
34
A rare case of renal angiomyolipoma involved both inferior vena cava and pulmonary arteries. ( 29707365 )
2018
35
Angiomyolipoma of the Adrenal Gland: A Report of Two Cases and Review of the Literature. ( 28904331 )
2017
36
Hepatic Angiomyolipoma Staining in the Post-vascular Phase of Contrast-enhanced Ultrasound Due to the Presence of Macrophages. ( 29279500 )
2017
37
Re: Small (&amp;lt; 4 cm) Renal Tumors with Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma from Renal Cell Carcinoma. ( 29370605 )
2017
38
Pulmonary Lymphangiomyomatosis Associated with Renal and Hepatic Angiomyolipoma Mass in a Patient with Tuberous Sclerosis Complex. ( 29237943 )
2017
39
Giant renal angiomyolipoma: A case report. ( 28781806 )
2017
40
Recurrent, Giant Renal Angiomyolipoma Treated with Selective Arterial Embolization: A Case Report. ( 29275410 )
2017
41
Intermittent everolimus administration for renal angiomyolipoma associated with tuberous sclerosis complex. ( 28905429 )
2017
42
Fluorine-18-FDG PET/CT in a patient with angiomyolipoma: Response to mammalian target of rapamycin inhibitor therapy. ( 28697195 )
2017
43
Huge buccal angiomyolipoma: a rare entity. ( 28918977 )
2017
44
The sunburst sign in renal angiomyolipoma. ( 28828502 )
2017
45
Epithelioid Angiomyolipoma - a case report and review of the literature. ( 29341516 )
2017
46
Renal Angiomyolipoma With Incidental Oncocytoma: A Case Report and Review of Literature. ( 29088523 )
2017
47
Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study. ( 28693223 )
2017
48
Ascending cholangitis: rare presentation of a ruptured right-sided renal angiomyolipoma. ( 29026516 )
2017
49
Clinical and genetic analysis of tuberous sclerosis complex-associated renal angiomyolipoma in Chinese pedigrees. ( 29344138 )
2017
50
Ang-1 and Ang-2 expression in angiomyolipoma and PEComa family tumors. ( 28053374 )
2017

Variations for Angiomyolipoma

Expression for Angiomyolipoma

Search GEO for disease gene expression data for Angiomyolipoma.

Pathways for Angiomyolipoma

Pathways related to Angiomyolipoma according to GeneCards Suite gene sharing:

(show all 26)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.62 CCL26 DES ESR1 KIT MTOR TSC1
2 12.61 ESR1 KIT MITF MTOR
3
Show member pathways
12.53 ESR1 KIT MTOR PGR
4
Show member pathways
12.32 ESR1 MITF MTOR TSC1 TSC2
5
Show member pathways
12.11 MTOR TSC1 TSC2
6
Show member pathways
12.09 KIT MTOR TSC1 TSC2
7 12.07 MTOR TSC1 TSC2
8
Show member pathways
12 MTOR TSC1 TSC2
9 11.96 MTOR TSC1 TSC2
10 11.96 MTOR TSC1 TSC2
11
Show member pathways
11.91 MTOR TSC1 TSC2
12
Show member pathways
11.9 MTOR TSC1 TSC2
13 11.81 MTOR TSC1 TSC2
14
Show member pathways
11.79 MTOR TSC1 TSC2
15
Show member pathways
11.79 MTOR TSC1 TSC2
16 11.74 ESR1 MTOR TSC2
17 11.7 MTOR TSC1 TSC2
18 11.64 ESR1 MTOR TSC1 TSC2
19 11.56 MTOR TSC1 TSC2
20 11.33 MTOR TSC1 TSC2
21 11.22 MTOR TSC1 TSC2
22 11.09 MTOR TSC2
23 11.03 MTOR TSC2
24 10.79 MTOR TSC1
25 10.66 MTOR TSC1 TSC2
26 10.55 ESR1 MTOR TSC1 TSC2

GO Terms for Angiomyolipoma

Cellular components related to Angiomyolipoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytoplasm GO:0005737 9.65 ACTC1 DES ESR1 KIT MITF MTOR
2 protein-containing complex GO:0032991 9.46 ESR1 MITF MTOR TSC1
3 TSC1-TSC2 complex GO:0033596 8.62 TSC1 TSC2

Biological processes related to Angiomyolipoma according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.67 ACTC1 KIT MITF MTOR
2 positive regulation of protein kinase B signaling GO:0051897 9.65 ESR1 KIT MTOR
3 cell cycle arrest GO:0007050 9.63 MTOR TSC1 TSC2
4 negative regulation of TOR signaling GO:0032007 9.54 TSC1 TSC2
5 negative regulation of insulin receptor signaling pathway GO:0046627 9.52 TSC1 TSC2
6 positive regulation of macroautophagy GO:0016239 9.51 TSC1 TSC2
7 stem cell differentiation GO:0048863 9.49 ESR1 KIT
8 melanocyte differentiation GO:0030318 9.43 KIT MITF
9 regulation of osteoclast differentiation GO:0045670 9.4 MITF MTOR
10 negative regulation of macroautophagy GO:0016242 9.32 MTOR TSC1
11 anoikis GO:0043276 9.26 MTOR TSC2
12 negative regulation of cell size GO:0045792 9.16 MTOR TSC1
13 positive regulation of phospholipase C activity GO:0010863 8.96 ESR1 KIT
14 pigmentation GO:0043473 8.8 KIT MITF TYR

Molecular functions related to Angiomyolipoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 steroid binding GO:0005496 8.62 ESR1 PGR

Sources for Angiomyolipoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....